Stock PHIA PHILIPS NV
Add to a list
To use this feature you must be a member
Log inSign up

Financials Philips NV

Equities

PHIA

NL0000009538

Advanced Medical Equipment & Technology

Market Closed - Euronext Amsterdam
Other stock markets
 11:35:03 2024-05-24 am EDT 		5-day change 1st Jan Change
24.97 EUR +1.09% Intraday chart for Philips NV -3.48% +22.47%
May. 24 Philips: refinancing for 700 million euros CF
May. 24 Royal Philips Prices EUR700 Million of Notes due 2032 MT

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 38,000 38,828 27,462 12,091 18,834 23,402 - -
Enterprise Value (EV) 1 42,022 42,536 32,138 18,178 24,651 28,330 28,019 27,036
P/E ratio 33.5 x 33.9 x 8.98 x -7.69 x -41.3 x 127 x 23.1 x 18.7 x
Yield 1.95% 1.94% 2.59% 6.07% 4.03% 3.34% 3.48% 3.65%
Capitalization / Revenue 1.95 x 1.99 x 1.6 x 0.68 x 1.04 x 1.25 x 1.19 x 1.14 x
EV / Revenue 2.16 x 2.18 x 1.87 x 1.02 x 1.36 x 1.51 x 1.42 x 1.31 x
EV / EBITDA 11.6 x 11.5 x 10.8 x 7.89 x 8.66 x 9.47 x 8.27 x 7.43 x
EV / FCF 39.9 x 23 x 35.7 x -18.9 x 15.6 x 23.8 x 37.4 x 17.3 x
FCF Yield 2.51% 4.35% 2.8% -5.29% 6.42% 4.2% 2.67% 5.78%
Price to Book 3.08 x 3.34 x 1.97 x 0.93 x 1.61 x 2.02 x 1.93 x 1.85 x
Nbr of stocks (in thousands) 962,448 958,166 905,498 932,751 923,773 937,203 - -
Reference price 2 39.48 40.52 30.33 12.96 20.39 24.97 24.97 24.97
Announcement Date 1/28/20 1/25/21 1/24/22 1/30/23 1/29/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 19,482 19,535 17,156 17,827 18,169 18,709 19,667 20,597
EBITDA 1 3,615 3,709 2,985 2,305 2,845 2,992 3,388 3,638
EBIT 1 2,563 2,570 2,054 1,318 1,921 2,169 2,368 2,599
Operating Margin 13.16% 13.16% 11.97% 7.39% 10.57% 11.59% 12.04% 12.62%
Earnings before Tax (EBT) 1 1,529 1,490 509 -1,731 -526 343.8 1,524 1,903
Net income 1 1,167 1,187 3,319 -1,608 -466 188.9 1,146 1,392
Net margin 5.99% 6.08% 19.35% -9.02% -2.56% 1.01% 5.83% 6.76%
EPS 2 1.179 1.194 3.379 -1.685 -0.4932 0.1959 1.083 1.333
Free Cash Flow 1 1,053 1,852 900 -961 1,582 1,191 749.4 1,562
FCF margin 5.4% 9.48% 5.25% -5.39% 8.71% 6.37% 3.81% 7.58%
FCF Conversion (EBITDA) 29.13% 49.93% 30.15% - 55.61% 39.81% 22.12% 42.92%
FCF Conversion (Net income) 90.23% 156.02% 27.12% - - 630.5% 65.39% 112.17%
Dividend per Share 2 0.7711 0.7868 0.7868 0.7868 0.8219 0.8346 0.8680 0.9126
Announcement Date 1/28/20 1/25/21 1/24/22 1/30/23 1/29/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2020 S1 2021 S1 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 S1 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 8,554 8,057 4,156 4,944 3,918 4,177 8,095 4,310 5,422 4,167 4,470 4,471 5,062 4,138 4,501 4,643 5,454 -
EBITDA - - - - - - - - - - - - 896 - 673.3 725.2 1,065 -
EBIT 662 - 512 - 243 216 459 209 651 359 453 457 653 - 475 582.6 837.3 -
Operating Margin 7.74% - 12.32% - 6.2% 5.17% 5.67% 4.85% 12.01% 8.62% 10.13% 10.22% 12.9% - 10.55% 12.55% 15.35% -
Earnings before Tax (EBT) - - - - - - - - 7 - - 130 - - - - - -
Net income 1 246 - 2,973 157 -151 -22 -173 -1,330 -106 - 72 88 39 -999 711.7 247.2 217.3 -
Net margin 2.88% - 71.54% 3.18% -3.85% -0.53% -2.14% -30.86% -1.95% - 1.61% 1.97% 0.77% -24.14% 15.81% 5.33% 3.98% -
EPS 2 - - 2.999 0.1666 -0.1574 -0.0185 - -1.388 -0.1111 - 0.0774 0.0870 0.0387 -1.064 0.7614 0.2652 0.2281 -
Dividend per Share 2 - - - 0.7868 - - - - 0.7868 - - - - - - - - -
Announcement Date 7/20/20 7/26/21 10/18/21 1/24/22 4/25/22 7/25/22 7/25/22 10/24/22 1/30/23 4/24/23 7/24/23 10/23/23 1/29/24 4/29/24 - - - -
1EUR in Million2EUR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 4,022 3,708 4,676 6,087 5,817 4,928 4,617 3,634
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 1.113 x 0.9997 x 1.566 x 2.641 x 2.045 x 1.647 x 1.363 x 0.9989 x
Free Cash Flow 1 1,053 1,852 900 -961 1,582 1,191 749 1,562
ROE (net income / shareholders' equity) 14.9% 9.7% 25.3% 6.1% 9.08% 11.2% 12.9% 13.6%
ROA (Net income/ Total Assets) 6.94% 6.63% 5.1% 2.74% 3.82% 2.93% 3.68% 4.66%
Assets 1 16,817 17,906 65,043 -58,658 -12,197 6,443 31,150 29,858
Book Value Per Share 2 12.80 12.10 15.40 13.90 12.70 12.40 12.90 13.50
Cash Flow per Share 2 2.020 2.800 1.660 -0.1800 2.250 1.790 1.730 2.470
Capex 1 978 924 729 788 554 962 988 1,040
Capex / Sales 5.02% 4.73% 4.25% 4.42% 3.05% 5.14% 5.03% 5.05%
Announcement Date 1/28/20 1/25/21 1/24/22 1/30/23 1/29/24 - - -
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Philips NV

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
17
Last Close Price
24.97 EUR
Average target price
25.13 EUR
Spread / Average Target
+0.65%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

1st Jan change Capi.
PHILIPS NV Stock Philips NV
+22.47% 25.4B
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+10.03% 223B
DANAHER CORPORATION Stock Danaher Corporation
+13.59% 195B
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+20.01% 144B
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+30.83% 111B
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
+2.05% 65.01B
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+15.38% 53.02B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
+3.96% 50.45B
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
+8.37% 44.15B
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
+3.27% 36.45B
Other Advanced Medical Equipment & Technology
  1. Stock Market
  2. Equities
  3. PHIA Stock
  4. Financials Philips NV